ZEG.DE
Price:
$155.75
Market Cap:
$281.25B
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2003-12-02
Stock Exchange
XETRA
Ticker
ZEG.DE
Dividends are a key part of long-term returns for investors, and AstraZeneca PLC (ZEG.DE) has a track record worth reviewing. Looking at dividend history for ZEG.DE gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-08-07
Dividend Yield
1.54%
Annual Dividend
$0.88
P/E Ratio
30.13
Payout Ratio
0.58
Dividend per Share
$2.80
EPS
5.17
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-08-07 | $0.88136 | $0.88136 | 2025-09-08 | |
| 2025-02-20 | $1.9451 | $1.9451 | 2025-03-24 | |
| 2024-08-08 | $0.89845 | $0.89845 | 2024-09-09 | |
| 2024-02-22 | $1.80617 | $1.80617 | 2024-03-25 | |
| 2023-08-10 | $0.8313 | $0.8313 | 2023-09-11 | |
| 2023-02-23 | $1.8849 | $1.8849 | 2023-03-27 | |
| 2022-08-11 | $0.764 | $0.88456 | 2022-09-12 | 2022-07-29 |
| 2022-02-24 | $1.453 | $1.68228 | 2022-03-28 | |
| 2021-08-12 | $0.648 | $0.75025 | 2021-09-13 | |
| 2021-02-25 | $1.374 | $1.59082 | 2021-03-29 | |
| 2020-08-13 | $0.696 | $0.80583 | 2020-09-14 | 2019-10-24 |
The table below shows AstraZeneca PLC (ZEG.DE) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
AstraZeneca PLC (ZEG.DE) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Merck & Co., Inc. (6MK.DE) | 0.03% |
| Amgen Inc. (AMG.DE) | 0.03% |
| Thermo Fisher Scientific Inc. (TN8.DE) | 0.00% |
| Novo Nordisk A/S (NOV.DE) | 0.04% |
| Gilead Sciences, Inc. (GIS.DE) | 0.03% |
| Abbott Laboratories (ABL.DE) | 0.02% |
| Pfizer Inc. (PFE.F) | 0.07% |
| Pfizer Inc. (PFE.DE) | 0.07% |
| Sanofi (SNW.DE) | 0.05% |
| UnitedHealth Group Incorporated (UNH.DE) | 0.03% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like AstraZeneca PLC (ZEG.DE) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is ZEG.DE’s dividend yield?
What is the difference between regular and special dividends?
Has ZEG.DE increased its dividends over time?
Why might dividend history data be delayed?
How often does ZEG.DE pay dividends?
What factors impact ZEG.DE's dividend payments?
Can dividends change over time?
What is ZEG.DE’s next dividend date?